Last edition
News about "Blujepa "
GSK Q2 Sales Hit GBP 8 Billion, Driven Mainly by Specialty Medicines
GSK has delivered robust second-quarter 2025 results, fueled primarily by strong growth in its Specialty Medicines portfolio.
Blujepa | 31/07/2025 | By Dineshwori | 104
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members